Menin links estrogen receptor activation to histone H3K4 trimethylation

Cancer Research

Volumn 66, Issue 9, 2006, Pages 4929-4935

  Dreijerink, Koen M A ^a   Mulder, Klaas W ^a   Winkler, G Sebastiaan ^a   Höppener, Jo W M ^a   Lips, Cornelis J M ^a   Timmers, H Th Marc ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GROWTH PROMOTOR; HISTONE; METHIONINE; PROTEIN TFF1; UNCLASSIFIED DRUG; VITAMIN D;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION; HISTONES; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEINS;

EID: 33646401100     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4461     Document Type: Article

References (44)

1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-71.
2. Chandrasekharappa SC, Teh BT. Functional studies of the MEN1 gene. J Intern Med 2003;253:606-15.
3. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-7.
4. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68: 820-3.
5. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999;96: 143-52.
6. Heppner C, Bilimoria KY, Agarwal SK, et al. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 2001;20:4917-25.
7. Kim H, Lee JE, Cho EJ, Liu JO, Youn HD. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 2003;63:6135-9.
8. Lin SY, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003;113: 881-9.
9. Hughes CM, Rozenblatt-Rosen O, Milne TA, et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 2004;13:587-97.
10. Yokoyama A, Wang Z, Wysocka J, et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 2004;24:5639-49.
11. Santos-Rosa H, Schneider R, Bannister AJ, et al. Active genes are tri-methylated at K4 of histone H3. Nature 2002;419:407-11.
12. Guenther MG, Jenner RG, Chevalier B, et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A 2005;102:8603-8.
13. Milne TA, Hughes CM, Lloyd R, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 2005;102: 749-54.
14. Perissi V, Rosenfeld MG. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 2005;6:542-54.
15. 1 and S phase protein phosphatase that associates with Cdk2. Cell 1993;75:791-803.
16. Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387: 733-6.
17. Lavigne AC, Mengus G, Gangloff YG, Wurtz JM, Davidson I. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol Cell Biol 1999; 19:5486-94.
18. Cavailles V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A 1994;91: 10009-13.
19. Albert TK, Hanzawa H, Legtenberg YI, et al. Identification of a ubiquitin-protein ligase subunit within the CCR4-NOT transcription repressor complex. EMBO J 2002;21:355-64.
20. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 2004;101: 1892-7.
21. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-52.
22. Metivier R, Penot G, Hubner MR, et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003;115:751-63.
23. Boeger H, Griesenbeck J, Strattan JS, Kornberg RD. Nucleosomes unfold completely at a transcriptionally active promoter. Mol Cell 2003;11:667-73.
24. Danielian PS, White R, Lees JA, Parker MG. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992;11:1025-33.
25. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997;6:1169-75.
26. Bartsch D, Kopp I, Bergenfelz A, et al. MEN1 gene mutations in 12 MEN1 families and their associated tumors. Eur J Endocrinol 1998;139:416-20.
27. Miedlich S, Lohmann T, Schneyer U, Lamesch P, Paschke R. Familial isolated primary hyperparathyroidism: a multiple endocrine neoplasia type 1 variant? Eur J Endocrinol 2001;145:155-60.
28. Roijers JF, de Wit MJ, van der Luijt RB, Ploos van Amstel HK, Hoppener JW, Lips CJ. Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding. Eur J Clin Invest 2000;30:487-92.
29. Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases. Hum Mutat 1999;13:54-60.
30. Fujimori M, Shirahama S, Sakurai A, et al. Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism. Am J Med Genet 1998;80:221-2.
31. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitabayashi I, Tsukada T. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol 2004;24:6569-80.
32. Pray-Grant MG, Daniel JA, Schieltz D, Yates JR III, Grant PA. Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 2005;433:434-8.
33. Santos-Rosa H, Schneider R, Bernstein BE, et al. Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin. Mol Cell 2003;12: 1325-32.
34. Dou Y, Milne TA, Tackett AJ, et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 2005;121:873-85.
35. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. Histone H4-16 acetylation controls chromatin structure and protein interactions. Science 2006;311:844-7.
36. Ng HH, Robert F, Young RA, Strahl K. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell 2003;11:709-19.
37. Kang Z, Janne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 2004;18:2633-48.
38. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005;435:1262-6.
39. Sims RJ III, Nishioka K, Reinberg D. Histone lysine methylation: a signature for chromatin function. Trends Genet 2003;19:629-39.
40. Sedkov Y, Cho E, Petruk S, et al. Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila. Nature 2003:426:78-83.
41. INK4c. Proc Natl Acad Sci U S A 2005;102:14659-64.
42. Carling T. Molecular pathology of parathyroid tumors. Trends Endocrinol Metab 2001;12:53-8.
43. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER. Jr. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998;83:3965-72.
44. Agarwal SK, Novotny EA, Crabtree JS, et al. Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci U S A 2003;100:10770-5.